Last Round
Series A
Jul 26, 2024
Total Funding Raised
$28.6M
Company Overview
Bivision Pharma is a drug discovery, life sciences, and pharmaceuticals and biotechnology company that develops innovative therapies for ophthalmic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B2C
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bivision Pharma Comps
Public and private peers based on sector, stage, and business model.
Bivision Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 26, 2024 | ||||
| VC Round | May 14, 2024 | ||||
| Angel | May 1, 2022 |
Bivision Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 华金大道投资有限公司 | Series A |
| Kaitai Capital | Angel |
| Huajin Capital | Series A |
| Gaorong Capital | Series A, Angel, VC Round |
| Hongli Innovation Investment | Angel, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2024
$14M round led by Huajin Capital and 华金大道投资有限公司
- May 14, 2024
Led by Gaorong Capital and Hongli Innovation Investment.
Bivision Pharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Bivision Pharma's valuation, stock price, and market status.
